FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309402810> ?p ?o ?g. }

• W4309402810 endingPage "12174" @default.
• W4309402810 startingPage "12164" @default.
• W4309402810 abstract "Accumulating evidences confirm that epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement have coexisted in lung adenocarcinoma (LUAD). However, Its biological mechanism, clinicopathological features, and optimization of targeted drugs have not yet been completely elucidated.To explore the clinical profile of LUAD patients with co-mutations of EGFR and ALK genes, with hopes of scientifically guiding similar patients towards selected, targeted drugs.Two hundred and thirty-seven LUAD patients were enrolled. EGFR mutations were detected by the amplification refractory mutation system-peptide nucleic acid technique, while the expression of ALK rearrangement was screened by the 5'/3' imbalance strategy for reverse transcription followed by quantitative polymerase chain reaction analysis. The clinicopathological features of these patients were analysed retrospectively, and the follow-up data were collected.There were six cases with co-mutations of EGFR and ALK genes, which were more common in women, non-smoking and stage IV LUAD patients with bone metastasis, hence a positive rate of 2.53% (6/237). EGFR-tyrosine kinase inhibitors (EGFR-TKIs) were their preferred drugs for targeted therapy in these patients, with progression-free survival ranging from two months to six months.In Gannan region, the positive rate of co-mutations of EGFR and ALK genes in LUAD patients is relatively high, and the co-mutations are more common in women, non-smoking and stage IV patients with bone metastasis. These patients prefer EGFR-TKIs as their preferred targeted drugs, but the therapeutic effect is not good. EGFR/ALK dual-TKIs may be more effective targeted drugs, which needs further study." @default.
• W4309402810 created "2022-11-26" @default.
• W4309402810 creator A5005063736 @default.
• W4309402810 creator A5067310135 @default.
• W4309402810 date "2022-11-26" @default.
• W4309402810 modified "2023-09-25" @default.
• W4309402810 title "Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study" @default.
• W4309402810 cites W1973016854 @default.
• W4309402810 cites W2126927831 @default.
• W4309402810 cites W2134897113 @default.
• W4309402810 cites W2140333474 @default.
• W4309402810 cites W2168977308 @default.
• W4309402810 cites W2172010139 @default.
• W4309402810 cites W2512516686 @default.
• W4309402810 cites W2517708875 @default.
• W4309402810 cites W2609001553 @default.
• W4309402810 cites W2765831845 @default.
• W4309402810 cites W2766925380 @default.
• W4309402810 cites W2795721215 @default.
• W4309402810 cites W2887380463 @default.
• W4309402810 cites W2919601798 @default.
• W4309402810 cites W2922780430 @default.
• W4309402810 cites W2939690516 @default.
• W4309402810 cites W2941929873 @default.
• W4309402810 cites W2942446777 @default.
• W4309402810 cites W2969705930 @default.
• W4309402810 cites W2980579765 @default.
• W4309402810 cites W2990041408 @default.
• W4309402810 cites W3001100920 @default.
• W4309402810 cites W3013456140 @default.
• W4309402810 cites W3101089668 @default.
• W4309402810 cites W3166021199 @default.
• W4309402810 cites W3205316782 @default.
• W4309402810 cites W4200399062 @default.
• W4309402810 doi "https://doi.org/10.12998/wjcc.v10.i33.12164" @default.
• W4309402810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36483819" @default.
• W4309402810 hasPublicationYear "2022" @default.
• W4309402810 type Work @default.
• W4309402810 citedByCount "0" @default.
• W4309402810 crossrefType "journal-article" @default.
• W4309402810 hasAuthorship W4309402810A5005063736 @default.
• W4309402810 hasAuthorship W4309402810A5067310135 @default.
• W4309402810 hasBestOaLocation W43094028101 @default.
• W4309402810 hasConcept C104317684 @default.
• W4309402810 hasConcept C117643217 @default.
• W4309402810 hasConcept C121608353 @default.
• W4309402810 hasConcept C126322002 @default.
• W4309402810 hasConcept C143998085 @default.
• W4309402810 hasConcept C170493617 @default.
• W4309402810 hasConcept C2776232967 @default.
• W4309402810 hasConcept C2776256026 @default.
• W4309402810 hasConcept C2778164965 @default.
• W4309402810 hasConcept C2778820342 @default.
• W4309402810 hasConcept C2779013556 @default.
• W4309402810 hasConcept C2779422266 @default.
• W4309402810 hasConcept C2779438470 @default.
• W4309402810 hasConcept C2781182431 @default.
• W4309402810 hasConcept C2781230642 @default.
• W4309402810 hasConcept C42362537 @default.
• W4309402810 hasConcept C501734568 @default.
• W4309402810 hasConcept C502942594 @default.
• W4309402810 hasConcept C55493867 @default.
• W4309402810 hasConcept C71924100 @default.
• W4309402810 hasConcept C86803240 @default.
• W4309402810 hasConceptScore W4309402810C104317684 @default.
• W4309402810 hasConceptScore W4309402810C117643217 @default.
• W4309402810 hasConceptScore W4309402810C121608353 @default.
• W4309402810 hasConceptScore W4309402810C126322002 @default.
• W4309402810 hasConceptScore W4309402810C143998085 @default.
• W4309402810 hasConceptScore W4309402810C170493617 @default.
• W4309402810 hasConceptScore W4309402810C2776232967 @default.
• W4309402810 hasConceptScore W4309402810C2776256026 @default.
• W4309402810 hasConceptScore W4309402810C2778164965 @default.
• W4309402810 hasConceptScore W4309402810C2778820342 @default.
• W4309402810 hasConceptScore W4309402810C2779013556 @default.
• W4309402810 hasConceptScore W4309402810C2779422266 @default.
• W4309402810 hasConceptScore W4309402810C2779438470 @default.
• W4309402810 hasConceptScore W4309402810C2781182431 @default.
• W4309402810 hasConceptScore W4309402810C2781230642 @default.
• W4309402810 hasConceptScore W4309402810C42362537 @default.
• W4309402810 hasConceptScore W4309402810C501734568 @default.
• W4309402810 hasConceptScore W4309402810C502942594 @default.
• W4309402810 hasConceptScore W4309402810C55493867 @default.
• W4309402810 hasConceptScore W4309402810C71924100 @default.
• W4309402810 hasConceptScore W4309402810C86803240 @default.
• W4309402810 hasIssue "33" @default.
• W4309402810 hasLocation W43094028101 @default.
• W4309402810 hasLocation W43094028102 @default.
• W4309402810 hasLocation W43094028103 @default.
• W4309402810 hasOpenAccess W4309402810 @default.
• W4309402810 hasPrimaryLocation W43094028101 @default.
• W4309402810 hasRelatedWork W1591408781 @default.
• W4309402810 hasRelatedWork W1889913689 @default.
• W4309402810 hasRelatedWork W2042683997 @default.
• W4309402810 hasRelatedWork W2167257097 @default.
• W4309402810 hasRelatedWork W2174684187 @default.
• W4309402810 hasRelatedWork W2413293760 @default.
• W4309402810 hasRelatedWork W2516942920 @default.

• next